BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2008
View Archived Issues
Bristol-Myers Squibb presents overview of second quarter
Read More
FDA has granted orphan drug designation to Ikaria's inhaled carbon monoxide for DGF
Read More
[11C]MePPEP, a novel PET ligand for CB1 shows good uptake and slow washout in human brain
Read More
Preclinical activity supports development of antiinfective acne treatment HB-1345
Read More
Preclinical positive results for serotonin receptor antagonists in learning and memory processing
Read More
Further phase II data on dimebon in Alzheimer's disease presented
Read More
New preclinical, phase I data on CTS-21166 made available
Read More
Senexis identifies promising beta-amyloid aggregation inhibitor
Read More
Novel anticancer agents described in recent patents
Read More
FDA allows Medarex's IND application to initiate phase I clinical trial of MDX-1105
Read More
Lorus reports positive results from two toxicology studies of LOR-2040 in bladder cancer
Read More
Diatos initiates recruitment into phase II clinical trials of DTS-201 in prostate and breast cancer
Read More
New agents for anxiety, psychosis, depression, etc. revealed in patent literature
Read More
Recent patents report discovery of novel antidiabetic agents
Read More
BioAlliance and APR sign European licensing agreement for ondansetron RapidFilm
Read More
Hollis-Eden initiates phase I/II clinical trial of Triolex and methotrexate in RA
Read More
Clinical Data acquires Adenosine Therapeutics
Read More
Novartis completes recruitment into phase III study of salmon calcitonin
Read More
Generex is granted approval to initiate trial of Generex Oral-lyn in IGT
Read More
Meda submits registration application to the FDA for extra strength azelastine nasal spray
Read More
Cancidas approved for use in pediatric patients
Read More
Heplisav phase III study meets primary endpoint
Read More
Intercell completes acquisition of Iomai
Read More